期刊文献+

成人先天性心脏病的血管紧张素Ⅱ、醛固酮和去甲肾上腺素激活及临床意义 被引量:1

The leve of AngⅡ,ALD and EN and the chronic heart failure syndrome in adults with congenital heart disease
下载PDF
导出
摘要 目的探讨成人先天性心脏病(先心病)是否存在血管紧张素Ⅱ(AngⅡ)、醛固酮(ALD)和去甲肾上腺素(NE)激活及其临床意义。方法选取100例成人先心病患者,检测其AngⅡ、ALD和NE;另选取年龄及性别与之相匹配的30名健康体检成人作为对照组。结果成人先心病血循环中的AngⅡ(188.3±11.5)ng/L、ALD(546.1±42.3)pmol/L、NE(2.17±0.08)nmol/L与对照组比较明显增高(均P<0.01)。3个亚组随着疾病严重程度的加重,神经内分泌的激活就越明显。结论成人先心病的AngⅡ、ALD和NE明显激活并具有慢性心力衰竭的特征,并与疾病的严重性密切相系。 Objective To detect angiotensin Ⅱ (Ang Ⅱ ), aldosterone (ALD) and norepinephfine (NE), and explore whether Ang Ⅱ , ALD and EN activation exists in adults with congenital heart disease. Methods Ang Ⅱ , ALD and NE were determined in 100 adults with congenital heart disease, and 30 cases of the control group were enrolled in the study. Results The serum NE(2.17±0.08)nmol/L and the plasma AngⅡ (188.3±11.5) ng/L,ALD (546.1±42.3)pmol/L in adults with congenital heart disease were higher than that in normal controls (P〈0.01). There was a highly significant stepwise increase in Ang Ⅱ, ALD and NE according to New York Heart Association class, with even asymptomatic patients having evidence of significant neurohormonal activation. Conclusion Ang Ⅱ ,ALD and EN activation in adult congenital heart disease bears the hallmarks of chronic heart failure, relating to symptom severity.
出处 《中国心血管病研究》 CAS 2008年第3期161-163,共3页 Chinese Journal of Cardiovascular Research
基金 广西科技攻关项目(桂科攻0472002-30)
关键词 心脏病 心力衰竭 心脏缺损 先天性 血管紧张素Ⅱ 醛固酮 去甲肾上腺素 Heart diseases Heart failure Heart defects,congenital Angiotensin Ⅱ ,Aldosterone Norepinephrine
  • 相关文献

参考文献8

  • 1[1]Hopkins WE,Hall C.Paradoxical relationship between N-terminal proatrial natriuretic peptide and filling pressure in adults with cyanotic congenital heart disease.Circulation,1997,96:22152220.
  • 2[2]Aidan PB,Rakesh S,Marjolein L,et al.Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease.Circulation,2002,106:92-99.
  • 3李爱萍,陈光辉,李天德,刘航,易军,王莉.不同水平干预对AngII作用心肌细胞活力的影响[J].军医进修学院学报,2004,25(4):252-254. 被引量:8
  • 4[4]Eichhorn FJ.Prognosis determination in heart failure.Am J Med,2001,110:S14-36.
  • 5[5]Remme WJ,Sweddberg K.Diagnosis and Treatment of chronic heart failure.Eur Heart J,2001,22:1527-1560.
  • 6[6]Hoch M,Netz H.Heart failure in pediatric patients.Thorac Cardiovasc Surg,2005,53:129-134.
  • 7[7]Schrier RW,Abraham WT.Hormones and hemodynamics in heart failure.N Engl J Med,1999,341:577-585.
  • 8[8]Gatzoulis MA,Balaji S,Webber SA.et al.Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot:a multicentre study.Lancet,2000,356:975-981.

二级参考文献9

  • 1Wei C, Cardarelli MG, Downing SW, et al. The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes[J]. J Renin Angiotensin Aldos- terone Syst, 2000,1(4):379-84.
  • 2Simpson DG, Decker ML, Clark WA, et al. Contractile activity and cell-cell contact regulate myofibrillar organization in cultured cardiac myocytes[J].J Cell Biol,1993,123(2):323-336.
  • 3Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays[J].J Immunol Methods,1983,65(1-2):55-63.
  • 4Freimoser FM, Jakob CA, Aebi M, et al.The MTT [3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities[J], Appl Environ Microbiol,1999,65:3727-3729.
  • 5Matsubara H.Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases[J]. Circ Res,1998, 83 (12): 1182-1191.
  • 6Matsubara H, Iwasaka T. Angiotensin II receptor-mediated function un- masked by gene-engineered animals[J].Nippon Rinsho,1999,57(5):1084-1089.
  • 7Pellieux C, Sauthier T, Aubert JF,et al. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen- activated protein kinase activation in normotensive and hypertensive mice[J]. J Hypertens,2000,18(9):1307-1317.
  • 8Morii I, Kihara Y, Inoko M, et al.Myocardial contractile efficiency and oxygen cost of contractility are preserved during transition from compensated hypertrophy to failure in rats with salt-sensitive hypertension[J].Hypertension,1998,31(4):949-960.
  • 9Gaballa MA, Goldman S. Ventricular remodeling in heart failure[J].J Card Fail,2002,8(6 Suppl):S476-485.

共引文献7

同被引文献8

  • 1Yang LZ, Tovote P, Rayner M, et al. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart. Eur J Pharmcol,2010,632: 1-6.
  • 2Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation, 2002,106 : 92-99.
  • 3Jacob J, Martin-Sanchez FJ, Herrero P, et al. Prognostic value of troponin in patients with acute heart failure attended in Span- ish Emergency Departments: TROPICA study (TROPonin in acute heart failure). Med Clin(Barc),2013,140:145-151.
  • 4Remme WJ, Swedberg K, Task Force for the Diagnosis and Treatment of Chronic Heart Failure, et al. Guidelines for the di- agnosis and treatment of chronic heart failure. Eur Heart J, 2001,22 : 1527-1560.
  • 5Hoch M, Netz H. Heart failure in pediatric patients. Thorac Car- diovasc Surg, 2005,53 : S 129-134.
  • 6D'Aioia A, izzardi E, Buqatti S, et al. Effect of short-term in- fusive dobutamine therapy on thyroid hormone profile and hemo-dynamic parameters in patients with acute worsening heart failure and low-triiodothymnine syndrome. J Investig Med,2012,60: 907-910.
  • 7Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for ar- rhythmia and sudden cardiac death late after repair of tetralogy of Fallot : a multicentre study. Lancet, 2000,356 : 975-981.
  • 8俸勇强.新生儿先天性心脏病血清一氧化氮、血浆内皮素-1及血管紧张素Ⅱ水平的研究[J].中国心血管病研究,2011,9(1):29-31. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部